Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.19
BATS BZX Real-Time Price
As of 1:10pm ET
 +0.185 / +9.25%
Today’s Change
1.50
Today|||52-Week Range
5.44
-28.83%
Year-to-Date
Cancer doctors face next drug challenge
Jun 01 / FT.com - Paid Partner Content
 

Today’s Trading

Previous close2.00
Today’s open2.15
Day’s range2.06 - 2.19
Volume48,085
Average volume (3 months)1,842,836
Market cap$189.6M
Dividend yield--
Data as of 1:10pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)-8.82%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXGNAxoGen Inc+0.43+6.89%
IRIXIRIDEX Corp+0.20+1.41%
CUTRCutera Inc+0.40+3.81%
EARSAuris Medical Holdin...+0.32+8.25%
Data as of 12:55pm ET, 06/28/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs